Get started
Cybin Inc.Cybin Inc.Cybin Inc.

Cybin Inc.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.37 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.59 USD
Net income (FY)
‪−78.61 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪39.32 M‬
Beta (1Y)
2.13

Employees


Employees (FY)
50
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.57 M‬ USD

About Cybin, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Eric So
Website
cybin.com
Headquarters
Toronto
Founded
2016
IPO date
Jan 5, 2018
Identifiers
3
ISIN CA23256X4075
CFI code
ESVUFR
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Check out other big names from the same industry as HELP.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


PSIL
AdvisorShares Psychedelics ETF
Weight 3.77%
Market value ‪1.25 M‬

Explore more ETFs 

Frequently asked questions


The current price of HELP is 4.58 USD — it has increased by 0.94% in the past 24 hours. Watch Cybin Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cybin Inc. stocks are traded under the ticker HELP.
HELP stock has risen by 5.41% compared to the previous week, the month change is a −13.86% fall, over the last year Cybin Inc. has showed a −43.03% decrease.
We've gathered analysts' opinions on Cybin Inc. future price: according to them, HELP price has a max estimate of 93.44 USD and a min estimate of 7.95 USD. Watch HELP chart and read a more detailed Cybin Inc. stock forecast: see what analysts think of Cybin Inc. and suggest that you do with its stocks.
HELP reached its all-time high on Aug 2, 2021 with the price of 128.44 USD, and its all-time low was 1.08 USD and was reached on May 22, 2020. View more price dynamics on HELP chart.
See other stocks reaching their highest and lowest prices.
HELP stock is 9.20% volatile and has beta coefficient of 2.13. Track Cybin Inc. stock price on the chart and check out the list of the most volatile stocks — is Cybin Inc. there?
Today Cybin Inc. has the market capitalization of ‪214.09 M‬, it has decreased by −0.45% over the last week.
Yes, you can track Cybin Inc. financials in yearly and quarterly reports right on TradingView.
Cybin Inc. is going to release the next earnings report on Jul 1, 2026. Keep track of upcoming events with our Earnings Calendar.
HELP earnings for the last quarter are −0.99 USD per share, whereas the estimation was −0.76 USD resulting in a −30.53% surprise. The estimated earnings for the next quarter are −0.80 USD per share. See more details about Cybin Inc. earnings.
Cybin Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
HELP net income for the last quarter is ‪−43.32 M‬ USD, while the quarter before that showed ‪−33.34 M‬ USD of net income which accounts for 0.00% change. Track more Cybin Inc. financial stats to get the full picture.
No, HELP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 18, 2026, the company has 50 employees. See our rating of the largest employees — is Cybin Inc. on this list?
Like other stocks, HELP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cybin Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cybin Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cybin Inc. stock shows the sell signal. See more of Cybin Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.